---
$id: https://graph.org.ai/products/commodity/51182009
$type: Product
source: UNSPSC
code: "51182009"
title: "Methyltestosterone"
class: "51182000"
classTitle: "Androgens and androgen inhibitors"
family: "51180000"
familyTitle: "Hormones and hormone antagonists"
segment: "51000000"
segmentTitle: "Pharmaceutical Products incl. Contraceptives and Vaccines"


---

# Methyltestosterone

**UNSPSC Code**: 51182009
**Class**: [Androgens and androgen inhibitors](Androgens and androgen inhibitors.mdx)
**Family**: [Hormones and hormone antagonists](../Hormones and hormone antagonists.mdx)
**Segment**: [Pharmaceutical Products incl. Contraceptives and Vaccines](../../Pharmaceutical Products incl. Contraceptives and Vaccines.mdx)

This classification denotes a therapeutic androgen with the molecular formula C20H30O2, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier V9EFU16ZIF, chemically known as testosterone, 17-methyl- but generally known as 17-methyltestosterone, which bears US NIH Compound Identifier 6010. European Medicines Agency schedules Methyltestosterone in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB08876MIG. The term METHYLTESTOSTERONE is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 13, No. 12, 1959, List 3). World Health Organization schedules 17-methyltestosterone in its Anatomical Therapeutic Chemical (ATC) Classification. Most nations schedule methyltestosterone under HS 29372900 and SITC 54153. As of Q4 2014, METHYLTESTOSTERONE remains the US FDA Preferred Term for this commodity. Methyltestosterone bears US NLM identifiers UMLS ID C0718532 and NCI Concept Code C648. SMILES: OC1(C2(C(C3C(C4(C(=CC(=O)CC4)CC3)C)CC2)CC1)C)C.

